Clinical Trials
5 trialsNCT00050349 2017-03-01
EPO906 in Carcinoid and Other Neuroendocrine Tumors
Novartis
Phase 2 Completed
NCT00035113 2017-02-09
EPO906 Therapy in Patients With Prostate Cancer
Novartis
Phase 2 Completed
NCT00035087 2013-12-04
EPO906 Therapy in Patients With Advanced Colorectal Cancer
Novartis
Phase 2 Completed
NCT00035243 2012-04-17
EPO906 Therapy in Patients With Advanced Kidney Cancer
Novartis
Phase 2 Completed
NCT00035100 2012-04-16
EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer
Novartis
Phase 2 Completed